Clinical Trial Update: Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

View source ↗

Summary

Clinical trial update indicating that a study on human anti-human antibodies in Paroxysmal nocturnal hemoglobinuria (PNH) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paroxysmal Nocturnal Hemoglobinuria

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Paroxysmal Nocturnal Hemoglobinuria, PNH | Status: COMPLETED